Abstract
Background: The incidence of benign thyroid nodules (TN) is high. Minimally invasive ablation is a commonly used treatment in clinical practice. However, the distinctions in efficacy and safety between different ablation techniquesstill need to beclarified.Objectives: It aimed to compare the effects of ultrasound-guided radiofrequency ablation (RFA) and microwave ablation (MWA) in benign TN.Methods: 103 patients with benign TN were retrospectively included and allocated toa RFA group (n = 58) or a MWA group (n = 45). Baseline data and serum levels of inflammatory factors, nodule volume, and vascular endothelial growth factor (VEGF) expression in nodule tissues pre- and post-surgery were extracted.Results: No distinctions in baseline data were noted (P > 0.05). On day 1 after surgery, the levels of inflammatory factors were lower in the RFA group versus the MWA group; The volume reduction rate of the RFA group was higher at each time point after surgery; At 6 months after surgery, the RFA group had a lower rate of VEGF-positive cells and a higher proportion of negative + weakly positive cells (P < 0.05). The RFA group had a superiorresponse rate (94.83% vs. 77.78% in the MWA group), and a lowerincidence of adverse reactions (ARs)(13.79%), with faster recovery (P < 0.05).Conclusion: Ultrasound-guided RFA for benign TN is superior in reducing inflammatory stress, promoting nodule shrinkage, and inhibiting VEGF expression.
Keywords
References
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.